Abstract
Several different types of leukocytes can destroy cancer cells in vitro (Klein et al., 1960; Hibbs et al., 1972; Herberman et al., 1975; Kiessling et al., 1975). Rather little, however, is known about the relative importance of these different leukocytes in the normal host, where they may exert a surveillance function and prevent the outgrowth of potentially malignant cells. We have studied the relative efficiency of the different leukocytes in restraining malignant growth in vivo by comparing the effects of the leukocytes on regressor tumors and on progressively growing tumor variants that have escaped the immunity of the host. This type of approach is based on the premise that if a leukocyte operates effectively in vivo in restraining the growth of a tumor, a tumor cell must become resistant to it before it can grow progressively. A study of such phenotypic changes in tumor variants should therefore give insight into the relative importance and hierarchy of the different naturally occurring immune defense cells. This type of analysis is analogous to that performed by the microbiologist who deduces the mechanism of action of an antibiotic from the type of change found in a bacterium that has become resistant to the drug.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Adams, D. O., and Snyderman, R., 1979, Do macrophages destroy nascent tumors? J. Natl. Cancer Inst. 62: 1341–1345.
Cikes, M., Friberg, S. Jr., and Klein, G., 1973, Progressive loss of H-2 antigens with comcommitant increase of cell surface antigen(s) determined by Moloney leukemia virus in cultered murine lymphomas, J. Natl. Cancer Inst. 50: 347–362.
Flood, P. M., Kripke, M. L., Rowley, D. A., and Schreiber, H., 1980, Suppression of tumor rejection by autologous anti-idiotypic immunity, Proc. Natl. Acad. Sci. USA 77: 2209–2213.
Flood, P. M., Urban, J. L., Kripke, M. L., and Schreiber, H., 1981, Loss of tumor-specific and idiotype-specific immunity with age, J. Exp. Med. 154: 275–290.
Hanna, N., and Burton, R. D., 1981, Definite evidence that natural killer cells inhibit experimental tumor metastasis in vivo, J. Immunol. 127: 1754–1758.
Hanna, N., and Fidler, I. J., 1980, Role of natural killer cells in the destruction of circulating tumor emboli, J. Natl. Cancer Inst. 65: 801–809.
Herberman, R. B., Nunn, M. E., and Lavrin, D. H., 1975, Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and phenotype, Int. J. Cancer 16: 216–229.
Hibbs, J. B., Jr., Lambert, L. H., Jr., and Remington, J. S., 1972, Control of carcinogenesis: A possible role for the activated macrophage, Science 177: 998–1000.
Kiessling, R., Klein, E., and Wigzell, H., 1975, Natural killer cells in the mouse. I. Cytotoxic cells with specificity for mouse leukemia cells. Specificity and distribution according to genotype, Eur. J. Immunol. 5: 112–117.
Klein, G., Sjögren, H. O., Klein, E., and Hellström, K. E., 1960, Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host, Cancer Res. 20: 1561–1572.
Kripke, M., 1981, Immunoglobulin mechanisms in UV radiation carcinogenesis, Adv. Cancer Res. 34: 69–106.
Loveland, B. E., and McKenzie, I. F. C., 1982, Which T cells cause graft rejection? Transplantation (Baltimore) 33:217–221.
Meltzer, M. S., 1981, Macrophage activation for tumor cytotoxicity: Characterization of priming and trigger signals during lymphokine activation, J. Immunol. 127: 179–183.
Nowell, P. C., 1976, The clonal evolution of tumor cell populations. Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression, Science 194: 23–28.
Pace, J. L., and Russell, S. W., 1981, Activation of mouse macrophages for tumor cell killing. I. Quantitative analysis of interactions between lymphokine and lipopolysaccharide, J. Immunol. 126: 1863–1867.
Urban, J. L., and Schreiber, H., 1983, Selection of macrophage-resistant progressor tumor variants by the normal host. Requirement for concomitant T cell-mediated immunity, J. Exp. Med. 157: 642–656.
Urban, J. L., Burton, B. C., Holland, J. M., Kripke, M. L., and Schreiber, H., 1982a, Mechanisms of syngeneic tumor rejection: Susceptibility of host-selected progressor variants to various immunological effector cells, J. Exp. Med. 155: 557–573.
Urban, J. L., Holland, J. M., Kripke, M. L., and Schreiber, H., 1982b, Immunoselection of tumor cell variants by mice suppressed with ultraviolet radiation, J. Exp. Med. 156: 1025–1041.
Wortzel, R. D., Urban, J. L., Philipps, C., Fitch, F. W., and Schreiber, H., 1983a, Independent immunodominant and immunorecessive tumor-specific antigens on a malignant tumor. Antigenic dissection with cytolytic T cell clones, J. Immunol. 130: 2461–2466.
Wortzel, R. D., Philipps, C., and Schreiber, H., 1983b, Multiple tumor-specific antigens on a single malignant cell, Nature 304: 165–167.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer Science+Business Media New York
About this chapter
Cite this chapter
Urban, J., Schreiber, H. (1984). Surveillance Role of Various Leukocytes in Preventing the Outgrowth of Potentially Malignant Cells. In: Adams, D.O., Hanna, M.G. (eds) Macrophage Activation. Contemporary Topics in Immunobiology, vol 13. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1445-6_11
Download citation
DOI: https://doi.org/10.1007/978-1-4757-1445-6_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-1447-0
Online ISBN: 978-1-4757-1445-6
eBook Packages: Springer Book Archive